The transcription factor STAT5 acts as an oncoprotein in B cell acute lymphoblastic leukemia, competing with the transcription factors NF-κB and Ikaros for binding to DNA.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Murphy, S.L., Xu, J. & Kochanek, K.D. Natl. Vital Stat. Rep. 61, 1–117 (2013).
Inaba, H., Greaves, M. & Mullighan, C.G. Lancet 381, 1943–1955 (2013).
Katerndahl, C.D.S. et al. Nat. Immunol. 18, 694–704 (2017).
Heltemes-Harris, L.M. & Farrar, M.A. Curr. Opin. Immunol. 24, 146–152 (2012).
Hoelbl, A. et al. EMBO Mol. Med. 2, 98–110 (2010).
Schwaller, J. et al. Mol. Cell 6, 693–704 (2000).
Malin, S., McManus, S. & Busslinger, M. Curr. Opin. Immunol. 22, 168–176 (2010).
Malin, S. et al. Nat. Immunol. 11, 171–179 (2010).
Mullighan, C.G. et al. Nature 446, 758–764 (2007).
Whyte, W.A. et al. Cell 153, 307–319 (2013).
Mullighan, C.G. et al. N. Engl. J. Med. 360, 470–480 (2009).
Kuiper, R.P. et al. Leukemia 24, 1258–1264 (2010).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
K.J.P. has patent applications related to the treatment of B-ALL and is the founder of Elf Zone, a company that develops cancer therapeutics and tools for cancer research.
Rights and permissions
About this article
Cite this article
Dovat, S., Payne, K. STAT5 alters the state of transcriptional networks, driving aggressive leukemia. Nat Immunol 18, 597–598 (2017). https://doi.org/10.1038/ni.3747
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni.3747